News

October 4, 2024
  • • News
    •

    Certificate of maximum commercial 2024 reliability CRIBIS

    Also this year, we obtained the CERTIFICATE OF MAXIMUM COMMERCIAL RELIABILITY awarded by Cribis. This certificate confirms that our company's business activity is aimed at a rigorous...
    September 3, 2024
  • • News
    •

    FULTON AT CPHI 2024

    Fulton will be present at the next CPhI Worldwide 2024 in Milan from October 8th to 10th. You can find us at stand  14F30. To...
    February 9, 2023
  • • News
    •

    Certificate of maximum commercial reliability CRIBIS

    We are proud to publish the CERTIFICATE OF MAXIMUM COMMERCIAL RELIABILITY awarded by Cribis. This is the result of the continuous and rigorous commitment that...
    November 24, 2022
  • • News
    •

    New authorization IMP (CAPSULES and BIOLOGICAL PRODUCTS)

    Fulton received from AIFA a new authorization for the Investigational Medicinal Product (IMP) production of biological products in hard capsules.
    April 14, 2022
  • • News
    •

    INPRO IN SAUDI ARABIA

    Our INPRO has successfully completed the registration process in Saudi Arabia, thanks to the collaboration of Pharmart and Arabian Trade House, and will be soon present on...
    August 30, 2021
  • • News
    •

    LACTOFERRIN FULTON IN UAE

    Fulton, with PHARMALINK, have received registration certificate for the products LACTIFOL (B9Ferrina) and FERIKKTO (Fe2Ferrina) in United Arab Emirates (UAE).